Cephalon Inc. v. Sandoz Inc.
Summary
Cephalon sues Sandoz and generic drugmakers for infringing patents on the pharmaceutical product.
Summary generated by AI from public docket data. Verify against the original filing before relying on it.
Counsel of record
For the plaintiff
- Bayard, P.A.Stephen B. Brauerman
- Gould & Ratner LLPVanessa Ribeiro Tiradentes
- UNDELIVERABLE EMAIL 5/28/2021Sara E. Bussiere
For the defendant
- Independent counselEric M. Acker, Sailesh K. Patel
- Connolly Gallagher LLPRyan Patrick Newell
- Flaster Greenburg, P.C.William J. Burnett
- Flaster/Greenburg P.C.Damien Nicholas Tancredi
- Heyman Enerio Gattuso & Hirzel LLPDominick T. Gattuso
- Smith, Katzenstein, & Jenkins LLPNeal C. Belgam
- UNDELIVERABLE EMAIL 10/15/2020Stephen D. Keane
- UNDELIVERABLE EMAIL 7/1/2021David C. Doyle
- UNDELIVERABLE EMAIL 8/17/2016Gina M. Bassi
- ADDRESS EXPIRED / UNKNOWNMary Matterer
- Court
- DED
- Docket no.
- 1:15-cv-00178
- Nature of suit
- Patent
- Filed
- 2015-02-23
- Last filing
- 2017-06-30
- Terminated
- 2017-06-29
Cause
35:271 Patent Infringement
Entities in this case
Parties
Glenmark Generics Inc USA Glenmark Generics Ltd. West-Ward Pharmaceuticals Corp. Eurohealth International SARL Glenmark Generics S.A. Glenmark Pharmaceuticals Ltd. Onco Therapies Limited Agila Specialties Inc. InnoPharma Inc. Intas Pharmaceuticals Ltd. Accord Healthcare Inc. Sandoz Inc. Cephalon Inc.